Pot luck? Medical marijuana's 'questionable quality’ no threat to pharma R&D
Pharma firms using cannabis-derived ingredients have hit out at the lack of standardization and the questionable quality of medical marijuana.
Pharma firms using cannabis-derived ingredients have hit out at the lack of standardization and the questionable quality of medical marijuana.
update
Denmark has bid to be the new home of the European Medicines Agency (EMA) after the UK leaves the European Union.
DCAT Week
This year, DCAT Week ’17 attendees can expect several new additions to the industry event as it gathers at its new location next month in New York City.
AMRI has entered an alliance through which the global contract research and manufacturing organization will gain access to "new avenues of drug discovery."
MedNet Solutions’ latest release of its eClinical solution, iMedNet™, features various updates that it says helps further decrease study build times.